Title |
MERS-CoV Antibodies in Humans, Africa, 2013–2014 - Volume 22, Number 6—June 2016 - Emerging Infectious Diseases journal - CDC
|
---|---|
Published in |
Emerging Infectious Diseases, June 2016
|
DOI | 10.3201/eid2206.160064 |
Pubmed ID | |
Authors |
Anne Liljander, Benjamin Meyer, Joerg Jores, Marcel A. Müller, Erik Lattwein, Ian Njeru, Bernard Bett, Christian Drosten, Victor Max Corman |
Abstract |
Dromedaries in Africa and elsewhere carry the Middle East respiratory syndrome coronavirus (MERS-CoV). To search for evidence of autochthonous MERS-CoV infection in humans, we tested archived serum from livestock handlers in Kenya for MERS-CoV antibodies. Serologic evidence of infection was confirmed for 2 persons sampled in 2013 and 2014. |
X Demographics
The data shown below were collected from the profiles of 52 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 7 | 13% |
United Kingdom | 7 | 13% |
Kenya | 4 | 8% |
Germany | 3 | 6% |
France | 2 | 4% |
Brazil | 2 | 4% |
Saudi Arabia | 2 | 4% |
Netherlands | 2 | 4% |
South Africa | 2 | 4% |
Other | 10 | 19% |
Unknown | 11 | 21% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 34 | 65% |
Scientists | 8 | 15% |
Practitioners (doctors, other healthcare professionals) | 7 | 13% |
Science communicators (journalists, bloggers, editors) | 3 | 6% |
Mendeley readers
The data shown below were compiled from readership statistics for 110 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | <1% |
Greece | 1 | <1% |
Unknown | 108 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 26 | 24% |
Student > Master | 17 | 15% |
Student > Ph. D. Student | 11 | 10% |
Other | 7 | 6% |
Professor > Associate Professor | 7 | 6% |
Other | 20 | 18% |
Unknown | 22 | 20% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 23 | 21% |
Medicine and Dentistry | 20 | 18% |
Biochemistry, Genetics and Molecular Biology | 13 | 12% |
Veterinary Science and Veterinary Medicine | 12 | 11% |
Immunology and Microbiology | 7 | 6% |
Other | 8 | 7% |
Unknown | 27 | 25% |
Attention Score in Context
This research output has an Altmetric Attention Score of 78. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 July 2020.
All research outputs
#557,967
of 25,757,133 outputs
Outputs from Emerging Infectious Diseases
#717
of 9,785 outputs
Outputs of similar age
#10,974
of 369,079 outputs
Outputs of similar age from Emerging Infectious Diseases
#13
of 132 outputs
Altmetric has tracked 25,757,133 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 9,785 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 46.0. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 369,079 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 132 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.